Evaluation of the effects of intraoperative ultrasonography in revision parotidectomy

Evaluation of the effects of intraoperative ultrasonography on surgical results and complications in revision parotidectomy in patients reffered to taleghani hospital between 1404 and 1405

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250914067234N2

Enrollment

Registered

2026-03-01

Start date

2026-02-28

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign neoplasm of parotid gland. Benign neoplasm of parotid gland

Interventions

Intervention 1: Intervention group: Patients in the intervention group undergo ultrasound guidance during revision parotidectomy surgery. Intervention 2: Control group: Patients in the control group u

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: History of surgery for benign parotid mass Possibility of regular follow-up No ban on general anesthesia Patients' willingness to undergo re-surgery No smoking or drug use Candidate for revision parotidectomy

Exclusion criteria

Exclusion criteria: Systemic diseases History of neck radiotherapy Facial nerve palsy

Design outcomes

Primary

Measure	Time frame
Facial nerve palsy. Timepoint: Immediately after surgery, 1 month, 3 months, and 6 months later. Method of measurement: Clinical examination.	—

Secondary

Measure	Time frame
Postoperative infection rate. Timepoint: Immediately after surgery, and one month, three months, and six months later. Method of measurement: Clinical examination and laboratory testing.;Possibility of Frey syndrome. Timepoint: Immediately after surgery, and one month, three months, and six months later. Method of measurement: Clinical examination.;Incidence of surgical site hematoma. Timepoint: Immediately after surgery, and one month, three months, and six months later. Method of measurement: Clinical examination.;Incidence of surgical site sialocele. Timepoint: Immediately after surgery, and one month, three months, and six months later. Method of measurement: Clinical examination.	—

Measure

Time frame

Postoperative infection rate. Timepoint: Immediately after surgery, and one month, three months, and six months later. Method of measurement: Clinical examination and laboratory testing.;Possibility of Frey syndrome. Timepoint: Immediately after surgery, and one month, three months, and six months later. Method of measurement: Clinical examination.;Incidence of surgical site hematoma. Timepoint: Immediately after surgery, and one month, three months, and six months later. Method of measurement: Clinical examination.;Incidence of surgical site sialocele. Timepoint: Immediately after surgery, and one month, three months, and six months later. Method of measurement: Clinical examination.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirhossein Ehsani

Shahid Beheshti University of Medical Sciences

drehsani96@gmail.com009821230311

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026